Early Olezarsen Results Show 50% Reduction in Triglycerides
A drug targeting mRNA essential for APO C-III production provided a 50% reduction in triglycerides in BRIDGE-TIMI 73a, the largest ever observed in a controlled trial.
Source: medscape.com